mGem: Opening Env and harnessing NK cell effector functions to eliminate HIV-1-infected cells. [PDF]
Richard J, Finzi A.
europepmc +1 more source
Impact of afucosylation strategy on antibody function: a comparative study of glycoengineered anti-CD20 antibodies Obinutuzumab and Obinutuzumab beta. [PDF]
Shuang Q +11 more
europepmc +1 more source
HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicity. [PDF]
Tebaldi G +7 more
europepmc +1 more source
FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy. [PDF]
Marei HE +3 more
europepmc +1 more source
Specific depletion of TIGIT<sup>high</sup> CD226<sup>-</sup> clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting. [PDF]
Zhou H +13 more
europepmc +1 more source
Insights into ectodomain shedding as a novel target in natural killer cell-based immunotherapy for cancer. [PDF]
Pimenta R +5 more
europepmc +1 more source
The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines. [PDF]
Kľoc D +8 more
europepmc +1 more source
IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer. [PDF]
Hur J +11 more
europepmc +1 more source
A Rare Case of Adenoid Cystic Breast Cancer: A Case Report and Literature Review. [PDF]
Bterrani E +4 more
europepmc +1 more source

